Cash Flow - Edgewise Therapeutics, Inc. (EWTX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -143.82 | -109.03 | -91.95 | -52.64 | -33.51 | -14.63 | -9.17 |
| Cash flow from investing | -32.79 | -184.66 | 102.89 | -70.58 | -242.23 | -24.38 | -0.18 |
| Cash flow from financing | 196.09 | 249.25 | 53.17 | 129.64 | 186.38 | 120.28 | 24.80 |
| Change in cash | 19.48 | -44.43 | 64.10 | 6.43 | -89.35 | 81.26 | 15.45 |
Show Quarterly Cash Flow
Cash Flow - Edgewise Therapeutics, Inc. (EWTX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -42.54 | -38.59 | -34.78 | -32.58 | -37.87 | -26.96 | -27.37 | -26.10 | -28.60 | -26.83 | -22.06 | -20.23 | -22.83 | -11.82 | -12.00 | -16.25 | -12.57 | -9.42 | -8.26 | -9.77 | -6.06 | -4.64 | -3.27 | -3.99 | -2.74 |
| Cash flow from investing | 2.43 | 49.76 | 35.72 | -162.17 | 43.90 | 20.92 | 25.36 | 37.37 | -268.31 | 26.98 | 23.42 | 3.44 | 49.04 | -75.60 | -26.32 | -0.05 | 31.39 | 14.12 | -31.61 | -159.97 | -64.77 | -24.18 | -0.01 | -0.19 | -0.01 |
| Cash flow from financing | 12.17 | 3.98 | 1.66 | 188.23 | 2.22 | 2.90 | 3.33 | 1.95 | 241.07 | 52.99 | -0.21 | 0.37 | 0.02 | -0.34 | 129.73 | 0.18 | 0.07 | 0.29 | 0.04 | -0.90 | 186.95 | 95.00 | 25.14 | 0.14 | 186.95 |
| Change in cash | -27.94 | 15.15 | 2.60 | -6.52 | 8.26 | -3.14 | 1.32 | 13.22 | -55.83 | 53.14 | 1.15 | -16.42 | 26.24 | -87.75 | 91.41 | -16.11 | 18.89 | 5.00 | -39.83 | -170.63 | 116.12 | 66.19 | 21.86 | -4.04 | 184.20 |